PATENT CLAIM ANALYSIS

Application Number: 15982141
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["424", "133100"]

Abstract:
The present disclosure relates to compositions and methods of use comprising antibodies or binding fragments thereof further comprising universal Fc glycoforms.

Claim (Index 9):
The isolated antibody, or antigen-binding fragment thereof of  claim 8 , comprising H-CDR1, H-CDR2, and H-CDR3 selected from (i)-(iii):\n (i) H-CDR1 selected from SEQ ID NO:207, SEQ ID NO: 217, SEQ ID NO: 227; (ii) H-CDR2 selected from SEQ ID NO: 208; SEQ ID NO: 218, SEQ ID NO: 228; (iii) H-CDR3 selected from SEQ ID NO: 209, SEQ ID NO: 219, SEQ ID NO: 229; respectively; and comprising L-CDR1, L-CDR2 and L-CDR3 selected from (iv)-(vi): (iv) L-CDR1 selected from SEQ ID NO: 204; SEQ ID NO: 214, and SEQ ID NO: 224; (v) L-CDR2 selected from SEQ ID NO:205; SEQ ID NO: 215 and SEQ ID NO: 225; (vi) L-CDR3 selected from SEQ ID NO: 206, SEQ ID NO: 216 and SEQ ID NO: 226; respectively.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 93.0
- Lexical Diversity: 1.04762
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15011544', '15011543', '14798312', '14599174', '15683685']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7083558717206647
- 35 USC 102 Novelty (BERT): 0.7270829289350461
- Combined Prediction Score: 0.7102285774421029
- Mean Citation Score: 611.699212
- Max Citation Score: 860.38965
- Similarity Product: 797.3743684282242

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test